Ghias Rana, MD
Obstetrics & Gynecology · Onancock, VANPI 1497722839
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (50.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Intuitive Surgical at 52.1% of the total. Reporting peaked in 2020 at $3,231 and has fallen 83.9% since, to $519 in 2025. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $60.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- AbbVie$783
- Boston Scientific$603
- Sumitomo Pharma America, Inc.$264
- Astellas Pharma US Inc$214
- Urovant Sciences Inc$130
- plus $992 from 23 others
Across 35 payments — averaging $1799.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$63K
What the payments were for
- Travel & lodging$64410%
- Food & beverage$2,38438%
- Education$3,12450%
- Gifts$831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $3,250 |
| AbbVie | 31 | $783 |
| Boston Scientific | 4 | $603 |
| Sumitomo Pharma America, Inc. | 7 | $264 |
| Astellas Pharma US Inc | 6 | $214 |
| Urovant Sciences Inc | 4 | $130 |
| Axonics, Inc. | 6 | $115 |
| Exeltis, USA Inc. | 6 | $108 |
| Applied Medical Resources Corporation | 1 | $106 |
| Medtronic(2 entities) | 3 | $100 |
| Organon | 4 | $87 |
| Pfizer | 4 | $54 |
| KARL Storz Endoscopy-america | 1 | $43 |
| Myovant Sciences Inc. | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Bayer | 2 | $37 |
| Minerva Surgical, Inc | 2 | $33 |
| Biogen | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Coopersurgical, Inc. | 2 | $26 |
| Seqirus USA Inc | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Millicent US Inc | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Avanos Medical | 1 | $16 |
| Aspira Women's Health Inc | 1 | $15 |
| Meditrina | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,112
- GEMTESA$125
How this compares
$6,234 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 75 | $29,994 |
| MyrbetriqMirabegron | 33 | $20,190 |
| GemtesaVibegron | 11 | $10,152 |
| Estradiol | 73 | $2,092 |
| ValacyclovirValacyclovir Hcl | 19 | $833 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 45 | $630 |
| Medroxyprogesterone Acetate | 16 | $278 |
| Fluconazole | 35 | $159 |
| Oxybutynin Chloride | 12 | $137 |
| Ibuprofen | 28 | $115 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $54 | $29,99475 claims |
| Astellas Pharma US IncMyrbetriq | $214 | $20,19033 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $264 | $10,15211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in Onancock
- Thomas KimbleNorfolk$286K
- Jack AyoubLeesburg$279K
- Kurian ThottStafford$216K
- Nina SmithHarrisonburg$199K
- Joseph TroiseSalem$144K
- Bunan AlnaifChesapeake$139K
- James JonesRichmond$134K
- Melissa DelgadoVienna$95K
- Joann PinkertonCharlottesville$35K
- Kristin SchraaMechanicsville$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.